We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
-1.51%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$106M
AUM Growth
-$13.8M
Cap. Flow
-$2.56M
Cap. Flow %
-2.41%
Top 10 Hldgs %
44.3%
Holding
92
New
2
Increased
11
Reduced
51
Closed
4

Top Buys

Rank Stock Value
1
BDSX icon
Biodesix
BDSX
+$592K
2
MRNA icon
Moderna
MRNA
+$465K
3
PSNL icon
Personalis
PSNL
+$353K
4
MGNI icon
Magnite
MGNI
+$227K
5
MDXH icon
MDxHealth
MDXH
+$60.8K

Top Sells

Rank Stock Value
1
FPAY
FlexShopper
FPAY
+$552K
2
AKTS
Akoustis Technologies Inc
AKTS
+$464K
3
VCYT icon
Veracyte
VCYT
+$361K
4
REKR icon
Rekor Systems
REKR
+$344K
5
MDT icon
Medtronic
MDT
+$294K

Sector Composition

Rank Sector Weight
1 Healthcare 58.09%
2 Technology 26.18%
3 Communication Services 5.31%
4 Consumer Staples 4.28%
5 Industrials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
26
Pfizer
PFE
$143B
$1.28M 1.2%
45,675
-66
-0.1% -$1.82K
AUGX
27
DELISTED
Augmedix, Inc. Common Stock
AUGX
$1.25M 1.18%
1,417,068
-41,200
-3% -$85K
VFF icon
28
Village Farms International
VFF
$234M
$1.1M 1.04%
1,083,500
-29,500
-3% -$35.9K
TGT icon
29
Target
TGT
$65.6B
$1.08M 1.01%
7,275
-200
-3% -$31.5K
MDXH icon
30
MDxHealth
MDXH
$21.5M
$1.05M 0.99%
437,875
+22,650
+5% +$60.8K
OPRX icon
31
OptimizeRx
OPRX
$114M
$1.02M 0.96%
102,363
-3,100
-3% -$34.1K
AAPL icon
32
Apple
AAPL
$4.54T
$979K 0.92%
4,650
– –
TELA icon
33
TELA Bio
TELA
$32.7M
$960K 0.9%
204,350
-5,650
-3% -$29.8K
TCMD icon
34
Tactile Systems Technology
TCMD
$635M
$925K 0.87%
77,500
-2,400
-3% -$32.3K
COP icon
35
ConocoPhillips
COP
$147B
$915K 0.86%
8,000
– –
STRM
36
DELISTED
Streamline Health Solutions
STRM
$906K 0.85%
131,027
-2,100
-2% -$12.5K
XGN icon
37
Exagen
XGN
$109M
$898K 0.85%
493,321
-250
-0.1% -$423
MRNA icon
38
Moderna
MRNA
$21.8B
$876K 0.83%
7,375
+3,675
+99% +$465K
SKYT icon
39
SkyWater Technology
SKYT
$855K 0.81%
111,750
-6,000
-5% -$52.1K
GILD icon
40
Gilead Sciences
GILD
$162B
$853K 0.8%
12,433
-500
-4% -$33.4K
CIEN icon
41
Ciena
CIEN
$53.4B
$807K 0.76%
16,750
– –
FPAY
42
DELISTED
FlexShopper
FPAY
$797K 0.75%
622,750
-479,193
-43% -$552K
T icon
43
AT&T
T
$159B
$743K 0.7%
38,876
-166
-0.4% -$2.89K
BMY icon
44
Bristol-Myers Squibb
BMY
$133B
$706K 0.67%
16,991
+350
+2% +$15.7K
ATRC icon
45
AtriCure
ATRC
$1.92B
$693K 0.65%
30,450
+2,600
+9% +$60K
BAX icon
46
Baxter International
BAX
$13.5B
$686K 0.65%
20,509
– –
CSTL icon
47
Castle Biosciences
CSTL
$855M
$677K 0.64%
31,090
-1,050
-3% -$23.4K
VZ icon
48
Verizon
VZ
$195B
$673K 0.63%
16,308
-309
-2% -$12.5K
NXPI icon
49
NXP Semiconductors
NXPI
$57.8B
$659K 0.62%
2,450
– –
BLZE icon
50
Backblaze
BLZE
$823M
$658K 0.62%
106,835
– –
1
2
3 4

Similar funds

SVP
Strategic Value Partners Greenwich, Connecticut $133M AUM
PWP
Phillips Wealth Planners Starkville, Mississippi $133M AUM 20.41% 1-Year Est. Return
BF
Bonfire Financial Colorado Springs, Colorado $133M AUM 12.09% 1-Year Est. Return
SFG
Synergy Financial Group San Ramon, California $133M AUM 22.16% 1-Year Est. Return
HWMG
Harbour Wealth Management Group Daniel Island, South Carolina $133M AUM
FTEA
Forty-three Eighteen Advisors Bentonville, Arkansas $133M AUM
WT
WHI Trust Chicago, Illinois $133M AUM
BAM
Brickwood Asset Management London, United Kingdom $133M AUM 10.27% 1-Year Est. Return

Perkins Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Perkins Capital Management held 92 positions worth $106M, down 11% from $120M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Perkins Capital Management's Q2 2024 filing shows 2 new, 11 increased, 51 reduced and 4 closed positions. Its largest new stake was Biodesix: 20,739 shares worth $635K. The largest sale was FlexShopper, an estimated $552K.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 51% a quarter earlier, followed by Technology and Communication Services.

  • Perkins Capital Management's largest Q2 2024 buy was Biodesix: 20,739 shares worth $635K.
  • Perkins Capital Management added most to Moderna in Q2 2024, an estimated $465K increase.
  • Perkins Capital Management's biggest Q2 2024 reduction was FlexShopper, cutting an estimated $552K.
  • Perkins Capital Management fully exited Rekor Systems in Q2 2024, selling an estimated $344K.
  • Perkins Capital Management's ten largest holdings make up 44% of its $106M portfolio in Q2 2024.
  • Perkins Capital Management opened 2 new positions and closed 4 in Q2 2024.
  • Perkins Capital Management's portfolio value fell 11% quarter-over-quarter to $106M.

Based on Perkins Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.